Elevated expression levels of RAC1, IQGAP1, MYL6, DBN1, SLC2A1 and SLC2A3 were observed in acute myocardial infarction patients compared to healthy controls, suggesting a strong association with disease progression and indicating their potential as novel therapeutic targets. Here, SLC2A1 is linked to myocardial infarction.